Maltby- I've heard the same old thing for 5 yrs- bought inoto it at 23=-24 bucks a share and again at $15/share- all on the same old thing about Panzem- first the doseage in the trials were wrong, then the vehicle- It takes hundreds of millions to develop drugs- they just don't have the money to do it- choice- sell off assests like thalidomide, or " partner" with another company giveng them most of the profits- but you and george can keep osting and talk all you want about trials- another !#.50/share and I'm even. The bigest things that have changed over the past 5 yrs is the number of outstanding share ( that's gone up) and the Price /share- that's gone down just opinion
Market Data 
Markets 
AI
